Work Medical Technology Group Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.8M-14.4% YoYTTM through 30 Sep 2025
Net Income -$1.1MTTM through 30 Sep 2025
Free Cash Flow $4.9MTTM through 30 Sep 2025
Margins
| Current | |
|---|---|
| Gross Margin | 23.8% |
| EBITDA Margin | -1.6% |
| Operating Margin | -25.4% |
| Net Margin | -10.9% |
Returns
-5.1%ROE
-3.2%ROA
Balance Sheet Health
Debt / Equity0.30x
Current Ratio1.71x
Net Debt$2.3M
Cash & Equivalents$4.1M
Quality Metrics
Altman Z-Score1.13
Piotroski F-Score5 / 9
FCF Margin49.9%
Multi-Year Trend
RevenueFY2025: $9.8M
Diluted EPS-$0.04TTMFY2025: $-0.04
Dividend
No dividend
Capital Allocation
R&D Spend$435.3K
Capex Intensity13.5%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.